Maxygen Inc (MAXY) SEC Filing 8-K Material Event for the period ending Tuesday, November 6, 2012

Maxygen Inc

CIK: 1068796 Ticker: MAXY

View differences made from one to another to evaluate Maxygen Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Maxygen Inc.


Assess how Maxygen Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Maxygen Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: MAXY
CIK: 1068796
Form Type: 8-K Corporate News
Accession Number: 0001193125-12-454845
Submitted to the SEC: Tue Nov 06 2012 5:17:00 PM EST
Accepted by the SEC: Tue Nov 06 2012
Period: Tuesday, November 6, 2012
Industry: Commercial Physical And Biological Research
  1. Earnings Release
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: